Table 2.
Patient no. | Location tumour 1 | SUVmax tumour 1 | Location tumour 2 | SUVmax tumour 2 | ΔSUVa | ΔSUV%b |
---|---|---|---|---|---|---|
1 | Lung, left hilum | 7.90 | Left 5th rib | 7.30 | 0.60 | 8 |
2 | Lung, RUL | 6.30 | Lung, RUL | 4.30 | 2.00 | 32 |
3 | Lung, RUL | 16.2 | Liver | 14.3 | 1.90 | 12 |
4 | Lung, LLL | 8.00 | Larynx | 9.30 | 1.30 | 14 |
5 | Lung, right hilum | 18.2 | Lung, left | 24.6 | 6.40 | 26 |
6 | Lung, RML | 34.8 | Th 12 | 26.6 | 10.2 | 29 |
7 | Lung, RLL | 27.6 | Lung, LUL | 13.4 | 14.2 | 51 |
8 | Lung, RLL | 2.50 | Lung, RLL | 2.20 | 0.30 | 12 |
9 | Lung, LLL | 10.5 | Left iliac bone | 10.7 | 0.20 | 2 |
10 | Lung, RUL | 5.90 | Lung, right hilum | 3.60 | 2.30 | 29 |
11 | Lung, LUL | 16.5 | Right 6th rib | 4.10 | 12.4 | 75 |
12 | Lung, RUL | 22.3 | Lung, RML | 23.1 | 0.80 | 3 |
13 | Lung, RUL | 6.20 | Th 11 | 4.90 | 1.30 | 21 |
14 | Lung, right | 12.4 | Lung, LUL | 7.10 | 5.30 | 43 |
15 | Lung, RUL | 9.60 | Right adrenal gland | 5.70 | 3.90 | 41 |
16 | Lung, RUL | 13.2 | Right iliac crest | 3.00 | 10.2 | 77 |
17 | Lung, RLL | 7.20 | Right 5th rib | 5.30 | 1.90 | 26 |
18 | Lung, RML | 12.5 | Lung, RLL | 16.4 | 3.90 | 24 |
19 | Lung, RUL | 13.5 | Right PSIS | 11.4 | 2.10 | 16 |
20 | Lung, RLL | 5.40 | L1 | 6.40 | 1.00 | 16 |
21 | Lung, RML | 5.90 | Lung, RML | 4.10 | 1.80 | 31 |
Mean ± SD | 4.00 ± 4.22 | 28 ± 21 |
SUV max maximum standardized uptake value, RUL right upper lobe, RLL right lower lobe, LUL left upper lobe, RML right middle lobe, LLL left lower lobe, Th thoracic vertebra, L lumbar vertebra, PSIS posterior superior iliac spine, SD standard deviation of the mean
aThe absolute difference between the SUVmax of tumour 1 and SUVmax of tumour 2
bThe relative difference between the SUVmax of tumour 1 and the SUVmax of tumour 2, expressed in percentages of the highest SUVmax